Results 211 to 220 of about 448,489 (363)
Nicorandil and Contrast-Induced Nephropathy
Mustafa Karanfil +8 more
openaire +4 more sources
Effects of N-Acetylcysteine on Renal Hemodynamics in Contrast Media-Induced Nephropathy [PDF]
Stefan Krzossok +8 more
openalex +1 more source
Prolonged Gastrointestinal Transit Times and Dysmotility in m.3243A>G Mitochondrial Disease
Carriers of m.3243A>G mitochondrial disease have impaired mitochondrial adenosine triphosphate (ATP) production. Our findings indicate that patients exhibit gastrointestinal dysmotility as assessed by the wireless motility capsule SmartPill. This indicates a critical role of mitochondrial ATP in normal gastrointestinal function.
Simone Rask Nielsen +6 more
wiley +1 more source
Protective effects of anisodamine on contrast induced nephropathy in patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention [PDF]
F. Xianghua +6 more
openalex +1 more source
Abstract Infection is a known cause of abdominal aortic aneurysm (AAA), and matrix metalloproteases‐2 (MMP‐2) secreted by vascular smooth muscle cells (SMCs) plays a key role in the structural disruption of the middle layer of the arteries during AAA progression.
Yi‐Wen Lin +6 more
wiley +1 more source
Bright kidney: a sign of contrast induced nephropathy after percutaneous coronary intervention. [PDF]
Omote K, Aikawa T, Sunaga D, Funayama N.
europepmc +1 more source
N‐Acetylcysteine in Preventing Contrast‐Induced Nephropathy Assessed by Cystatin C [PDF]
Emin Alioğlu +8 more
openalex +1 more source
Abstract MicroRNAs (miRNAs or miRs) are small, non‐coding RNAs that play a crucial role in gene regulation, making them potential biomarkers for various diseases. In the field of veterinary medicine, there is a growing interest in exploring the diagnostic and therapeutic potential of miRNAs in kidney diseases affecting dogs and cats.
Candice P. Chu, Mary B. Nabity
wiley +1 more source
The Incidence of Contrast-Induced Nephropathy Following Computed Tomography and Associated Risk Factors. [PDF]
Mosaddegh R +6 more
europepmc +1 more source

